iShares Genomics Immunology and Healthcare Index ETF CAD (XDNA.TO) ETF Analysis

Fund Overview

iShares Genomics Immunology and Healthcare Index ETF CAD (XDNA.TO) is an exchange-traded fund. The fund holds CA$10.57M in total net assets. The fund is issued by BlackRock Asset Management Canada Ltd. It has been trading since April 26, 2022.

The largest positions on file are Bayer AG (BAYN.DE), Twist Bioscience Corp (TWST), and Revolution Medicines Inc Ordinary Shares (RVMD). Bayer AG alone accounts for 4.8% of the portfolio. The ten largest positions together make up 43.03% of the fund.

Performance Analysis

XDNA.TO last closed at CA$57.05 on September 4, 2026. The trailing one-year price return is +78.17%. Measured over 3 years, that is +22.76% a year compounded. The fund distributes at a trailing yield of 0.25%.

The strongest complete calendar year on file is 2025 at +12.10%; the weakest is 2023 at −7.84%. Of the 3 complete calendar years on file, 2 finished higher. 2026 is still running; the price is +53.57% year to date.

Price & Risk Profile

The 52-week range on file runs from CA$32.10 to CA$59.26. The latest close sits 77.73% above that 52-week low. Daily returns over the trailing 4 years annualize to a volatility of 24.83%. The reported beta is 1.34. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.